NCT04092101View on ClinicalTrials.gov

Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

October 18, 2020

Primary Completion Date

November 27, 2023

Study Completion Date

November 27, 2023

Conditions
Tobacco Use Disorder
Interventions
OTHER

Cigarettes with varying nicotine content

1\) Altering the nicotine content of the tobacco research cigarette

OTHER

E-Cigarettes

1\) Altering the availability of e-cigarettes; 2) Altering option to personalize the e-liquid in the e-cig condition

Trial Locations (2)

21287

Johns Hopkins University, Baltimore

05401

Shirley Plucinski, Burlington

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Johns Hopkins University

OTHER

lead

University of Vermont

OTHER

NCT04092101 - Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder | Biotech Hunter | Biotech Hunter